"Clinical Research Associates is a Nashville-based multi-specialty research firm that conducts clinical trials, and has contributed to FDA approval of more than 150 medicines during its 30-year history."

During the past decade, Clinical Research Associates, Inc. conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 45 clinical trials were completed, i.e. on average, 104.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 21 clinical trials were completed. i.e. 105% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Associates, Inc." #1 sponsor was "Pfizer" with 15 trials, followed by "Phathom Pharmaceuticals, Inc." with 4 trials sponsored, "Shire" with 4 trials sponsored, "BioNTech SE" with 3 trials sponsored and "Dermira, Inc." with 3 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Associates, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "AccuDial Pharmaceutical, Inc." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Associates, Inc." are "Migraine" (6 trials), "Influenza" (5 trials), "Smoking Cessation" (5 trials), "Binge Eating Disorder" (4 trials) and "Hypertension" (3 trials). Many other conditions were trialed in "Clinical Research Associates, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Research Associates, Inc." are "Drug" (57 trials), "Biological" (25 trials), "Other" (11 trials), "Behavioral" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Vonoprazan" (4 trials), "Rimegepant" (3 trials), "placebo" (3 trials) and "rLP2086" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Associates, Inc." are 72 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Associates, Inc.". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in Clinical Research Associates, Inc., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Associates, Inc., 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 0 trials that are defined as “Not Applicable".